Treatment of hereditary angiooedema.
D000799:Angioedema / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics; D003174:Complement C1 Inactivator Proteins / Q000096:biosynthesis / Q000172:deficiency; D003613:Danazol / Q000627:therapeutic use*; D006801:Humans; D011245:Pregnadienes / Q000627:therapeutic use*; D013268:Stimulation, Chemical
D003174:Complement C1 Inactivator Proteins; D011245:Pregnadienes; D003613:Danazol